Orthocell has appointed its second distributor in Canada. The appointment completes national coverage across the US$75 million Canadian market, ensuring access for patients and healthcare providers nationwide.<\/p>\n
The newly appointed Ontario-based distributor brings valuable experience across the nerve, spine and orthopaedic implant sectors and has been granted exclusive rights to represent Remplir in Saskatchewan, Manitoba, Ontario, Quebec, New Brunswick, Nova Scotia, Prince Edward Island and Newfoundland. Orthocell\u2019s existing distributor will continue to service Alberta and British Columbia, ensuring seamless national coverage.<\/p>\n
Following the successful launch of Remplir at the Annual Meeting of the American Society for Surgery of the Hand in Vancouver, first Canadian sales are expected this quarter<\/p>\n
Rollout activities in Canada will be overseen by Orthocell\u2019s US-based Marketing and Medical Education team.<\/p>\n
Orthocell CEO and MD, Paul Anderson said:<\/p>\n
\u201cWe\u2019re very pleased to expand our Canadian distributor presence beyond Alberta and BC with this new appointment opening up the entire Canadian market.<\/em><\/p>\n Our focus remains on rolling out Remplir in the jurisdictions where we have regulatory approvals.\u00a0 The most efficient pathway to market is through in-country distributors that hold direct relationships with our end customers \u2013 surgeons and hospitals.<\/em><\/p>\n Each new distributor appointment is an important step, initiating targeted sales and marketing efforts in their territories and bringing us closer to generating new revenue streams.<\/em><\/p>\n We\u2019re building significant momentum with our distributor relationships globally, led by our US portfolio covering 25 states alongside recent appointments in Hong Kong and Canada, as well as our longer-term relationship with DVT in Australia and Singapore.\u201d<\/em><\/p>\n